Oxidative stress is considered to be one of the mechanisms leading to atherosclerosis. It occurs in response to injury or to altered metabolic state. Alterations in cell growth (proliferation or apoptosis) can also contribute to the pathogenesis of atherosclerosis and is influenced by oxidative stress. Smooth muscle cells (SMC) from aortic explants of JCR:LA-cp homozygous cp/cp corpulent rats who are genetically predisposed to develop atherosclerosis exhibit increased SMC proliferation, which can be attenuated by exercise and food restriction. This study was conducted to characterize the effects fo oxidative stress and high glucose media on cell growth and its relationship to mitochondrial DNA integrity and gene expression in explanted aortic SMC from corpulent and lean JCR:LA-cp rats. The results show that SMC from the cp/cp rat appear to be resistant to oxidant-induced cell death and that they accumulate mitochondrial DNA mutations, probably as a result of a reduction in apoptosis. These data suggest that susceptibility to age- and glucose-related atherosclerosis may be related to alterations in redox signaling.
BelchJJF, MackayIR, HillA, JenningsP, McCollumP.Oxidative stress is present in atherosclerotic peripheral arterial disease and further increased by diabetes mellitus. Int Angiol14:385–388, 1995.
2.
CrawfordDW, BlankenhornDH. Arterial wall oxygenation, oxyradicals, and atherosclerosis. Atherosclerosis89:97–108, 1991.
3.
AlexanderRW. Atherosclerosis as a disease of redox-sensitive genes. Trans Am Clin Climatol Ass109:129–145, 1998.
4.
IsnerJM, KearneyM, BortmanS, PasseriJ.Apoptosis in human atherosclerosis and restenosis. Circulation91:2703–2711, 1995.
5.
RemboldC.Could atherosclerosis originate from defective smooth muscle cell death (apoptosis)?Perspect Biol Med39:405–408, 1996.
6.
GreenDR, ReedJC. Mitochondria and apoptosis. Science281:1309–1312, 1998.
7.
WeiY-H. Oxidative stress and mitochondrial DNA mutations in human aging. Proc Soc Exp Biol Med217:53–63, 1998.
8.
LeeCM, WeindruchR, AikenJM. Age-associated alterations of the mitochondrial genome. Free Rad Biol Med22:1259–1269, 1997.
Wu-PengXS, ChuaSCJr, OkadaN, LiuS-M, NicolsonM, LeibelRL. Phenotype of the obese Koletsky (f) rat due to Tyr763stop mutation in the extracellular domain of the leptin receptor (lepr): Evidence for deficient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat. Diabetes46:513–518, 1997.
11.
RichardsonM, SchmidtAM, GrahamSE, AchenB, DeReskeM, RussellJC. Vasculopathy and insulin resistance in the JCR:LA-cp rat. Atherosclerosis138:135–146, 1998.
12.
AbsherPM, SchneiderDJ, RussellJC, SobelBE. Increased proliferation of explanted vascular smooth muscle cells: A marker presaging atherogenesis. Atherosclerosis131:187–194, 1997.
13.
RussellJC. The atherosclerosis-prone JCR:LA-corpulent rat. In: Woodford FP, DavignonJ, SnidermanA, Eds. Atherosclerosis X: Proceedings of the 10th International Symposium on Atherosclerosis. Amsterdam: Elsevier, pp121–125, 1995.
14.
AbsherPM, SchneiderDJ, BaldorLC, RussellJC, SobelBE. The retardation of vasculopathy induced by attenuation of insulin resistance in the corpulent JCR:LA-cp rat is reflected by decreased vascular smooth muscle cell proliferation in vivo. Atherosclerosis143:245–251, 1999.
15.
FukagawaNK, LiM, LiangP, RussellJC, SobelBE, AbsherPM. Aging and high concentrations of glucose potentiate injury to mitochondrial DNA. Free Rad Biol Med27:1437–1443, 1999.
16.
RussellJC, AmyRM, GrahamSE, WoodGO, Bar-TanaJ.Inhibition of atherosclerosis an myocardial lesions in the JCR:LA-cp rat by b,b′-tetramethylhexadecanedioci acid (MEDICA 16). Arterioscler Thromb Vasc Biol15:918–923, 1995.
17.
GadaletaG, PepeG, De CandiaG, QuagliarielloC, SbisàE, SacconeC.The complete nucleotide sequence of the Rattus norvegicus mitochondrial genome: Cryptic signals revealed by comparative analysis between vertebrates. J Mol Evol28:497–516, 1989.
18.
BalmainA, KrumlaufR, VassJK, BirnieGD. Cloning characterization of the abundant cytoplasmic 7S RNA from mouse cells. Nucleic Acids Res10:4259–4277, 1982.
19.
OzawaT.Oxidative damage and fragmentation of mitochondrial DNA in cellular apoptosis. Biosci Rep17:237–250, 1997.
20.
GriendlingKK, Ushio-FukaiM.Redox control of vascular smooth muscle proliferation. J Lab Clin Med132:9–15, 1998.
21.
CotgreaveIA, GerdesRG. Recent trends in glutathione biochemistry-glutathione-protein interactions: A modern link between oxidative stress and cell proliferation?Biochem Biophys Res Commun242:1–9, 1998.
22.
LiP-F, DietzR, von HarsdorfR.Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation96:3602–3609, 1997.
23.
AndreuAL, ArbosMA, Perez-MartosA, Lopez-PerezMJ, AsinJ, LopezN, MontoyaJ, SchwartzS.Reduced mitochondrial DNA transcription in senescent rat heart. Biochem Biophys Res Commun252:577–581, 1998.
24.
Marin-GarciaJ, AnanthakrishnanR, GoldenthalMJ. Mitochondrial gene expression in rat heart and liver during growth and development. Biochem Cell Biol75:137–142, 1997.
25.
BeziatF, MorelF, Volz-LingenholA, Saint PaulN, AlziariS.Mitochondrial genome expression in a mutant strain of D. subobscura, an animal model for large scale mtDNA deletion. Nucleic Acids Res21:387–392, 1993.
XuL, BadrMZ. Enhanced potential for oxidative stress in hyperin-sulinemic rats: Imbalance between hepatic peroxisomal hydrogen peroxide production and decomposition due to hyperinsulinemia. Horm Metab Res31:278–282, 1999.
28.
GraierWF, Grubenthal1, DittrichP, WascherTC, KostnerGM. Intracellular mechanism of high D-glucose-induced modulation of vascular cell proliferation. Eur J Pharmacol294:221–229, 1995.
NatarajanR, GonzalesN, XuL, NadlerJL. Vascular smooth muscle cells exhibit increased growth in response to elevated glucose. Biochem Biophys Res Commun187:552–560, 1992.
31.
YasunariK, KohnoM, KanoH, YokokawaK, MinamiM, YoshikawaJ.Mechanisms of action of troglitazone in the prevention of high glucose-induced migration and proliferation of cultured coronary smooth muscle cells. Circulation Res81:953–962, 1997.
32.
PatronoC, FitzGeraldGA. Isoprostanes: Potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol17:2309–2315, 1997.
33.
RudermanNB, WilliamsonJR, BrownleeM.Glucose and diabetic vascular disease. FASEB6:2905–2914, 1992.
34.
WangE.Regulation of apoptosis resistance and ontogeny of age-dependent diseases. Exp Gerontol32:471–484, 1997.
